June 09, 2025

AI: Superpower or Kryptonite? Cardiac Expert Weighs In

Artificial intelligence has arrived in medicine. Yet is it amplifying your clinical expertise or subtly undermining your patient care?

Baptist Health South Florida

June 02, 2025

Exercise After Chemotherapy Improves Colorectal Cancer Survival

A long-term clinical trial found that structured exercise after colon cancer treatment improved survival outcomes and reduced recurrence rates, offering evidence to support physical activity as part of survivorship care.

Conexiant

May 30, 2025

Extra Boost Before Surgery Shows Promise

Tevimbra added to chemo before esophageal cancer surgery doubled complete response rates in a phase 2 trial, hinting at a future shift in standard care.

Reuters

May 20, 2025

STIs Associated with Bacterial Vaginosis Recurrence

Large retrospective study finds gonorrhea infection significantly increases bacterial vaginosis recurrence odds by up to 549%.

Conexiant

May 20, 2025

ICU Sedation Economics: A $1 Difference

Study finds dexmedetomidine, clonidine, and propofol have comparable cost-effectiveness for critically ill patients on mechanical ventilation.

Conexiant

March 31, 2025

Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer

Removing and testing at least 18 lymph nodes during surgery was associated with more accurate staging and better survival rates for colon cancer patients, according to research presented today at the Society of Surgical Oncology 2025 Annual Meeting. The findings from researchers at Fox Chase Cancer Center challenge the current standard of care for staging colon cancer, which calls for removal and examination of 12 lymph nodes.

Fox Chase Cancer Center

May 05, 2025

Missed Screenings? Anal Cancer Surge in Women

Rates rising 4.3% in white women over 65, outpacing increases in other demographics.

Conexiant

May 06, 2025

Shorter Prostate Radiotherapy Proves Long-Term Match

Two-week radiation treatment for localized prostate cancer delivers equivalent 10-year outcomes to standard 8-week course in a clinical trial.

Conexiant

April 24, 2025

Old Drug, New Trick for Joint Pain

Can a common diabetes drug double as a treatment for knee osteoarthritis?

Conexiant